Jacob V. Aranda

8.3k total citations
221 papers, 6.1k citations indexed

About

Jacob V. Aranda is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jacob V. Aranda has authored 221 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Pediatrics, Perinatology and Child Health, 92 papers in Pulmonary and Respiratory Medicine and 45 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jacob V. Aranda's work include Neonatal Respiratory Health Research (84 papers), Neonatal Health and Biochemistry (43 papers) and Pharmaceutical studies and practices (37 papers). Jacob V. Aranda is often cited by papers focused on Neonatal Respiratory Health Research (84 papers), Neonatal Health and Biochemistry (43 papers) and Pharmaceutical studies and practices (37 papers). Jacob V. Aranda collaborates with scholars based in United States, Canada and United Kingdom. Jacob V. Aranda's co-authors include Kay D. Beharry, Allen H. Neims, Ronald Thomas, Tania R. Gunn, Tomris Türmen, Sylvain Chemtob, Eugene W. Outerbridge, Andrew Aldridge, Judith M. Collinge and Daya R. Varma and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Jacob V. Aranda

215 papers receiving 5.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jacob V. Aranda 2.7k 2.3k 1.0k 983 716 221 6.1k
Brian A. Darlow 3.3k 1.2× 3.4k 1.5× 1.3k 1.3× 473 0.5× 76 0.1× 190 6.1k
Paul Hjemdahl 485 0.2× 1.0k 0.5× 466 0.5× 584 0.6× 841 1.2× 359 11.7k
Pascal Nicod 733 0.3× 1.7k 0.7× 1.3k 1.3× 1.6k 1.6× 278 0.4× 195 13.7k
Peter W. de Leeuw 462 0.2× 1.3k 0.6× 392 0.4× 223 0.2× 466 0.7× 245 11.4k
Ehud Grossman 409 0.2× 826 0.4× 524 0.5× 435 0.4× 494 0.7× 400 10.3k
Ivan D. Frantz 731 0.3× 2.2k 0.9× 183 0.2× 813 0.8× 140 0.2× 143 5.2k
Steven J. Soldin 1.5k 0.6× 636 0.3× 134 0.1× 292 0.3× 577 0.8× 239 7.9k
Máximo Vento 4.1k 1.5× 7.6k 3.3× 547 0.5× 3.1k 3.1× 129 0.2× 380 12.8k
Brian J. Anderson 3.8k 1.4× 701 0.3× 282 0.3× 129 0.1× 2.2k 3.1× 233 9.2k
Rik C. Schoemaker 827 0.3× 277 0.1× 286 0.3× 409 0.4× 1.1k 1.6× 198 6.2k

Countries citing papers authored by Jacob V. Aranda

Since Specialization
Citations

This map shows the geographic impact of Jacob V. Aranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob V. Aranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob V. Aranda more than expected).

Fields of papers citing papers by Jacob V. Aranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob V. Aranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob V. Aranda. The network helps show where Jacob V. Aranda may publish in the future.

Co-authorship network of co-authors of Jacob V. Aranda

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob V. Aranda. A scholar is included among the top collaborators of Jacob V. Aranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob V. Aranda. Jacob V. Aranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aranda, Jacob V., et al.. (2025). Technology acceptance and use among nursing staff in Latin American hospitals: A mixed methods study. International Journal of Nursing Studies Advances. 8. 100290–100290.
2.
Cai, Charles L., et al.. (2024). Gut microbiome and inflammation in response to increasing intermittent hypoxia in the neonatal rat. Pediatric Research. 97(6). 2126–2135. 1 indexed citations
3.
Cai, Charles L., et al.. (2024). Comparison of Glutathione Nanoparticles, CoEnzyme Q10, and Fish Oil for Prevention of Oxygen-Induced Retinopathy in Neonatal Rats. Pharmaceuticals. 17(3). 381–381. 1 indexed citations
4.
Cai, Charles L., et al.. (2024). Early versus late caffeine and/or non‐steroidal anti‐inflammatory drugs (NSAIDS) for prevention of intermittent hypoxia‐induced neuroinflammation in the neonatal rat. International Journal of Developmental Neuroscience. 84(3). 227–250. 2 indexed citations
5.
Yazdanyar, Amirfarbod, Charles L. Cai, Jacob V. Aranda, Eric Shrier, & Kay D. Beharry. (2023). Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells. Pharmaceuticals. 16(7). 939–939. 2 indexed citations
6.
Cai, Charles L., et al.. (2023). Coenzyme Q10 and Fish Oil Supplementation for Reducing Retinal Oxidative Stress in a Rat Model. Vision. 7(1). 20–20. 2 indexed citations
7.
8.
Beharry, Kay D., et al.. (2023). Factors Influencing Neonatal Gut Microbiome and Health with a Focus on Necrotizing Enterocolitis. Microorganisms. 11(10). 2528–2528. 13 indexed citations
9.
Cai, Charles L., et al.. (2021). Dose Response of Bumetanide on Aquaporins and Angiogenesis Biomarkers in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia. Pharmaceuticals. 14(10). 967–967. 1 indexed citations
10.
Cai, Charles L., et al.. (2021). Renal biomarkers of acute kidney injury in response to increasing intermittent hypoxia episodes in the neonatal rat. BMC Nephrology. 22(1). 299–299. 5 indexed citations
11.
Cai, Charles L., et al.. (2021). Antioxidants and/or fish oil reduce intermittent hypoxia-induced inflammation in the neonatal rat terminal ileum. Prostaglandins & Other Lipid Mediators. 155. 106565–106565. 2 indexed citations
12.
Cai, Charles L., et al.. (2021). Pharmacodynamic Effects of Standard versus High Caffeine Doses in the Developing Brain of Neonatal Rats Exposed to Intermittent Hypoxia. International Journal of Molecular Sciences. 22(7). 3473–3473. 8 indexed citations
13.
Cai, Charles L., et al.. (2021). Growth factors in the fetus and pre-adolescent offspring of hyperglycemic rats. Diabetes and Vascular Disease Research. 18(2). 1476853713–1476853713. 2 indexed citations
14.
Cai, Charles L., et al.. (2021). Comparison of coenzyme Q10 or fish oil for prevention of intermittent hypoxia-induced oxidative injury in neonatal rat lungs. Respiratory Research. 22(1). 196–196. 5 indexed citations
15.
Cai, Charles L., et al.. (2021). Effects of omega 3 polyunsaturated fatty acids, antioxidants, and/or non‐steroidal inflammatory drugs in the brain of neonatal rats exposed to intermittent hypoxia. International Journal of Developmental Neuroscience. 81(5). 448–460. 6 indexed citations
16.
Duggan, Thomas J., Charles L. Cai, Jacob V. Aranda, & Kay D. Beharry. (2020). Acute and chronic effects of intravitreal bevacizumab on lung biomarkers of angiogenesis in the rat exposed to neonatal intermittent hypoxia. Experimental Lung Research. 47(3). 1–15. 6 indexed citations
17.
Cai, Charles L., et al.. (2020). Bumetanide Suppression of Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy. International Journal of Molecular Sciences. 21(3). 987–987. 6 indexed citations
18.
19.
20.
Beharry, Kay D., et al.. (2018). Oxygen-Induced Retinopathy from Recurrent Intermittent Hypoxia Is Not Dependent on Resolution with Room Air or Oxygen, in Neonatal Rats. International Journal of Molecular Sciences. 19(5). 1337–1337. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian A. Darlow Breakdown of academic impact, for papers by Paul Hjemdahl Breakdown of academic impact, for papers by Pascal Nicod Breakdown of academic impact, for papers by Peter W. de Leeuw Breakdown of academic impact, for papers by Ehud Grossman Breakdown of academic impact, for papers by Ivan D. Frantz Breakdown of academic impact, for papers by Steven J. Soldin Breakdown of academic impact, for papers by Máximo Vento Breakdown of academic impact, for papers by Brian J. Anderson Breakdown of academic impact, for papers by Rik C. Schoemaker
Rankless by CCL
2026